Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Natural selection, protein engineering, and the last riboorganism: rational model building in biochemistry.
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
View in:
PubMed
subject areas
Allergens
Benzhydryl Compounds
Double-Blind Method
Histamine
Histamine H1 Antagonists
Histamine Release
Humans
Nasal Cavity
Nasal Provocation Tests
Premedication
Rhinitis, Allergic, Seasonal
Terfenadine
Therapeutic Irrigation
authors with profiles
Robert M. Naclerio